Approval · Notice of Compliance 469 · 2003
DESOXI: Notice of Compliance 469
Issued September 4, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 469
- Date
- September 4, 2003
- Company
- Taropharma, A Division Of Taro Pharmaceuticals Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
- Canadian reference product
- TOPICORT
Products in this notice
Medicinal ingredients
- DESOXIMETASONE 0.25 PER
- DESOXIMETASONE 0.05 PER